Revance Therapeutics Inc (RVNC)

[vinmantoo]

Dew, thanks for that information. It is good to correct some errors, I will call them honest mistakes to be kind, that mrwilson has posted. This part from the RVNC CC is worth repeating.

As a reminder, with a new toxin, physicians tend to start patients at the lower end of the dosing range before titrating them up over subsequent treatment cycles. In order to find the optimal balance between symptom control and safety, despite being early in the dose optimization journey. When surveyed 94% of previous physicians who have been in the program since its inception indicated that they perceived diversified to last longer than other toxins based on their first treatment cycle.

I assume there was a transcribing error as it should have read

When surveyed 94% of previous physicians who have been in the program since its inception indicated that they perceived Daxxify to last longer than other toxins based on their first treatment cycle.